Jansen Syndrome With Unaccountable Severe Hypercalcemia Treated by Biphosphanate

被引：0

作者：

Keskin, Mehmet ^{[1
]}

Keskin, Ozlem ^{[1
]}

Kor, Deniz ^{[1
]}

Uyanik, Hatice ^{[1
]}

Aksoy, Mehmet ^{[1
]}

Palali, Fatih ^{[1
]}

机构：

[1] Gaziantep Univ, Dept Paediat, TR-27310 Gaziantep, Turkey

来源：

ENDOCRINOLOGIST | 2010年 / 20卷 / 04期

关键词：

Jansen syndrome; hypercalcemia; biphosphanate; METAPHYSEAL CHONDRODYSPLASIA; BISPHOSPHONATES; PAMIDRONATE;

D O I：

10.1097/TEN.0b013e3181e9494c

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

We describe the use of pamidronate to control marked hypercalcemia in a girl with Jansen-type of metaphyseal chondrodysplasia. She was suffering from an unspecified interstitial lung disease and severe hypercalcemia. She was first treated with intravenous fluids, furosemide, calcitonin, and glucocorticoids without significant improvement, but became normocalcemic within 24 hours of receiving a single dose of pamidronate.

引用

页码：160 / 161

页数：2

共 8 条

[1] Severe infantile hypercalcemia associated with Williams syndrome successfully treated with intravenously administered pamidronate
Cagle, AP
Waguespack, SG
Buckingham, BA
Shankar, RR
DiMeglio, LA
[J]. PEDIATRICS, 2004, 114 (04) : 1091 - 1095
[2] THE JANSEN TYPE OF METAPHYSEAL CHONDRODYSPLASIA - CONFIRMATION OF DOMINANT INHERITANCE AND REVIEW OF RADIOGRAPHIC MANIFESTATIONS IN THE NEWBORN AND ADULT
CHARROW, J
POZNANSKI, AK
[J]. AMERICAN JOURNAL OF MEDICAL GENETICS, 1984, 18 (02): : 321 - 327
[3] BISPHOSPHONATES - PHARMACOLOGY AND USE IN THE TREATMENT OF TUMOR-INDUCED HYPERCALCEMIC AND METASTATIC BONE-DISEASE
FLEISCH, H
[J]. DRUGS, 1991, 42 (06) : 919 - 944
[4] Neonatal hyperparathyroidism and pamidronate therapy in an extremely premature infant
Fox, Lisa
Sadowsky, Joel
Pringle, Kevin P.
Kidd, Alexa
Murdoch, Jean
Cole, David E. C.
Wiltshire, Esko
[J]. PEDIATRICS, 2007, 120 (05) : E1350 - E1354
[5] 2 UNUSUAL CASES OF NEPHROCALCINOSIS IN INFANCY
KESSEL, D
HALL, CM
SHAW, DG
[J]. PEDIATRIC RADIOLOGY, 1992, 22 (06) : 470 - 471
[6] Mechanism of action, pharmacokinetic and pharmacodynamic profile, and clinical applications of nitrogen-containing bisphosphonates
Kimmel, D. B.
[J]. JOURNAL OF DENTAL RESEARCH, 2007, 86 (11) : 1022 - 1033
[7] CALCIUM-METABOLISM IN THE JANSEN TYPE OF METAPHYSEAL DYSPLASIA
KRUSE, K
SCHUTZ, C
[J]. EUROPEAN JOURNAL OF PEDIATRICS, 1993, 152 (11) : 912 - 915
[8] FURTHER CLINICAL AND RADIOLOGICAL FEATURES IN METAPHYSEAL CHONDRODYSPLASIA JANSEN TYPE
NAZARA, Z
HERNANDEZ, A
CORONARIVERA, E
VACA, G
PANDURO, A
MARTINEZBASALO, C
CANTU, JM
[J]. RADIOLOGY, 1981, 140 (03) : 697 - 700

← 1 →